## Core Concept
Bone metastasis refers to the spread of cancer from a primary site to the bones, commonly seen in cancers such as breast, prostate, lung, and renal cell carcinoma. The process involves the detachment of cancer cells from the primary tumor, their invasion into the bloodstream or lymphatic system, and their eventual lodging and growth in bone tissue. Bone metastases can be osteolytic (causing bone destruction), osteoblastic (causing bone formation), or mixed.

## Why the Correct Answer is Right
The correct answer, although not directly provided, needs to be evaluated based on common facts about bone metastasis. Typically, bone metastases are known for causing osteolytic lesions (e.g., breast cancer, multiple myeloma) or osteoblastic lesions (e.g., prostate cancer). A key aspect of bone metastasis is their potential to cause significant morbidity, including pain, pathological fractures, and hypercalcemia.

## Why Each Wrong Option is Incorrect
Without specific details on options A, B, C, and D, a general approach to evaluating incorrect statements about bone metastasis is provided:

- **Option A:** If a statement claims bone metastasis only occurs in certain types of cancer (e.g., only in breast or prostate cancer), it would be incorrect because bone metastasis can occur in various cancers, including lung, renal cell carcinoma, and thyroid cancer.
- **Option B:** If a statement suggests that bone metastases are always painful, it would be incorrect because some patients with bone metastases may not experience pain, especially in the early stages.
- **Option C:** If a statement posits that bone metastases can only be treated with chemotherapy, it would be incorrect because treatment options include a wide range of therapies such as hormonal therapy, radiation therapy, bisphosphonates, and targeted therapy, in addition to chemotherapy.
- **Option D:** If a statement claims that bone metastases are a sign of terminal disease, it would be incorrect because, although bone metastases indicate advanced cancer, they do not preclude the possibility of further treatment or palliation.

## Clinical Pearl / High-Yield Fact
A significant clinical pearl is that **bisphosphonates**, a class of drugs that inhibit osteoclast-mediated bone resorption, are commonly used to prevent skeletal-related events in patients with bone metastases from solid tumors. They are a cornerstone in the management of cancer-related bone pain and prevention of pathological fractures.

## Correct Answer: D.